4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001808296-26-000004
Director sold 2,625 shares at $10.73 ($28,166)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farzan Nima Director | 2026-06-04 | Sale 10b5-1 | −2,625 | $10.73 | $28,166 | 9,767 | D: show line 1 in the form |
| Open-market sales · 2,625 sh · avg $10.73 · $28,166 | |||||||
Loading xslF345X06/form4-06082026_080648.xml…